vimarsana.com

Page 2 - Managing Directorgv Prasad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Reddy s developing new treatment options for COVID-19, says MD

Dr Reddy s developing new treatment options for COVID-19, says MD SECTIONS Last Updated: May 23, 2021, 11:21 AM IST Share Synopsis We are motivated to serve patients in every possible way and with utmost urgency. This is reflected in the multiple collaborations we have entered to develop and commercialise a wide range of preventive and curative options for COVID treatment, Dr Reddy s Laboratories Co-Chairman & Managing Director G V Prasad said in an analyst call. Agencies The Hyderabad-based drug major has already launched Sputnik V vaccine while partnering various organisations, including the Defence Research and Development Organisation. Drug major Dr Reddy s Laboratories is working on the development of new treatment options for COVID-19 patients which it aims to launch over the next few months while ensuring uninterrupted supplies of its existing range of products for the infectious disease in the market, according to a top company official. The Hyderabad-based drug maj

Dr Reddy s developing new treatment options for Covid-19, says MD | India News

Dr Reddy s Lab gets emergency use authorisation for Sputnik V in India

Dr Reddy s Lab gets emergency use authorisation for Sputnik V in India
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

Dr Reddy s Lab gets emergency use authorisation for Sputnik V in India | India News

HYDERABAD: Dr Reddy s Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import Sputnik vaccine into India for restricted use in emergency situations. The permission is subject to provisions of New Drug and Clincial Trials Rules 2019 under the Drugs and Cosmetics Act. In September last year, Dr Reddy s had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute the vaccine in India. In addition to trials conducted in Russia by RDIF. Phase two and three clinical trials of the vaccine were carried out by Dr Reddy s in India.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.